The early apoptosis rate of RAW264.7 cells using FITC-annexin 18 was higher than that of cells using FITC-annexin V, suggesting that SmANX 18 has a greater ability to combine with apoptotic cells of certain mammalian tumor cell lines. The gene discussed is ANXA5; the disease is neoplasm.